High number of PD ‐1 positive intratumoral lymphocytes predict survival benefit of CIK cells for hepatocellular carcinoma patients

ConclusionsA high number of PD‐1+ TILs can serve as a potent biomarker for adopting CIK cells therapy in HCC patients after curative resection.This article is protected by copyright. All rights reserved.

Source: Liver International - January 22, 2018 Category: Gastroenterology Authors: Boyang Chang, Lujun Shen, Kefeng Wang, Jietian Jin, Tao Huang, Qifeng Chen, Wang Li, Peihong Wu Tags: Original Article Source Type: research